These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
504 related articles for article (PubMed ID: 16810437)
21. Evaluation of susceptibility testing methods for polymyxin. Behera B; Mathur P; Das A; Kapil A; Gupta B; Bhoi S; Farooque K; Sharma V; Misra MC Int J Infect Dis; 2010 Jul; 14(7):e596-601. PubMed ID: 20045367 [TBL] [Abstract][Full Text] [Related]
22. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins. van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821 [TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414 [TBL] [Abstract][Full Text] [Related]
25. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Gales AC; Jones RN; Sader HS Clin Microbiol Infect; 2006 Apr; 12(4):315-21. PubMed ID: 16524407 [TBL] [Abstract][Full Text] [Related]
26. Susceptibility of gram-negative bacteria isolated from a paediatric hospital environment to antibiotics. Zembrzuska-Sadkowska E; Parnowska W; Werakso B; Najer A Acta Pol Pharm; 1995; 52(2):161-71. PubMed ID: 8960247 [TBL] [Abstract][Full Text] [Related]
27. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials. Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303 [TBL] [Abstract][Full Text] [Related]
28. Comparison of susceptibility testing methods for determining the activity of colistin against Gram-negative bacilli of clinical origin. Haeili M; Kafshdouz M; Pishnian Z; Feizabadi MM; Martinez-Martinez L J Med Microbiol; 2019 Jan; 68(1):60-66. PubMed ID: 30422106 [TBL] [Abstract][Full Text] [Related]
29. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Matthaiou DK; Michalopoulos A; Rafailidis PI; Karageorgopoulos DE; Papaioannou V; Ntani G; Samonis G; Falagas ME Crit Care Med; 2008 Mar; 36(3):807-11. PubMed ID: 18431267 [TBL] [Abstract][Full Text] [Related]
30. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis. Alhanout K; Brunel JM; Raoult D; Rolain JM J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647 [TBL] [Abstract][Full Text] [Related]
31. [Surveillance of resistance in the intensive care units using a cumulative antibiogram]. Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419 [TBL] [Abstract][Full Text] [Related]
32. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. Saghir S; Faiz M; Saleem M; Younus A; Aziz H Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404 [TBL] [Abstract][Full Text] [Related]
33. In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates. Jacquier H; Le Monnier A; Carbonnelle E; Corvec S; Illiaquer M; Bille E; Zahar JR; Jauréguy F; Fihman V; Tankovic J; Cattoir V; Microb Drug Resist; 2012 Aug; 18(4):396-401. PubMed ID: 22335615 [TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007). Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205 [TBL] [Abstract][Full Text] [Related]
35. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis. Briscoe D; Rubowitz A; Assia E Orbit; 2005 Mar; 24(1):29-32. PubMed ID: 15764113 [TBL] [Abstract][Full Text] [Related]
36. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina. Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C; Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645 [TBL] [Abstract][Full Text] [Related]
38. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007). Patzer JA; Dzierzanowska D; Turner PJ J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575 [TBL] [Abstract][Full Text] [Related]
39. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. Raja NS J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905 [TBL] [Abstract][Full Text] [Related]
40. [Sensitivity to colistin: evaluation of cut-off points available in disk diffusion test]. Rodríguez CH; Pautaso J; Bombicino K; Vay C; Famiglietti A Rev Argent Microbiol; 2004; 36(3):125-9. PubMed ID: 15559194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]